John Chalmers AC's Publications

About John Chalmers AC's Publications

Senior Director, Professorial Unit, The George Institute (Australia)
  • Professor of Medicine, UNSW Sydney
  • Emeritus Professor of Medicine at Flinders University and at the University of Sydney
  • FAA,
  • FAHMS,
  • FRACP

  • Cognitive function and risks of cardiovascular disease and hypoglycaemia in patients with type 2 diabetes: the Action in Diabetes and Vascular Disease: Preterax and Diamicron Modified Release Controlled Evaluation (ADVANCE) trial

    Diabetologia Date published:

  • Intensive glucose control and macrovascular outcomes in type 2 diabetes

    Diabetologia Date published:

  • Combined Effects of Routine Blood Pressure Lowering and Intensive Glucose Control on Macrovascular and Microvascular Outcomes in Patients With Type 2 Diabetes

    Diabetes Care Date published:

  • Blood Pressure Variables and Cardiovascular Risk

    Hypertension Date published:

  • Albuminuria and Kidney Function Independently Predict Cardiovascular and Renal Outcomes in Diabetes

    Journal of the American Society of Nephrology Date published:

  • JOINT EFFECTS OF BLOOD PRESSURE LOWERING AND GLUCOSE CONTROL IN THE ADVANCE TRIAL

    Date published:

  • INDEPENDENT IMPACT OF ALBUMINURIA AND KIDNEY FUNCTION ON CARDIOVASCULAR RISK IN PATIENTS WITH TYPE 2 DIABETES: RESULTS FROM THE ADVANCE TRIAL

    Date published:

  • THE FIXED COMBINATION OF PERINDOPRIL AND INDAPAMIDE HAS A GREATER EFFECT ON CARDIOVASCULAR OUTCOMES IN PATIENTS WITH TYPE 2 DIABETES AND ALBUMINURIA

    Date published:

  • THE EFFECTS OF A FIXED COMBINATION OF PERINDOPRIL AND INDAPAMIDE IN PATIENTS WITH TYPE 2 DIABETES MELLITUS ACCORDING TO BASELINE CARDIOVASCULAR RISK IN THE ADVANCE TRIAL

    Date published:

  • MEASURING AUSTRALIAN SALT INTAKES

    Date published:

  • Management of hypertension Evidence from the Blood Pressure Lowering Treatment Trialists’ Collaboration and from major clinical trials

    Polish Archives of Internal Medicine Date published:

  • Effects of the End Point Adjudication Process on the Results of the Perindopril Protection Against Recurrent Stroke Study (PROGRESS)

    Stroke Date published:

  • Severe Cerebral White Matter Hyperintensities Predict Severe Cognitive Decline in Patients With Cerebrovascular Disease History

    Stroke Date published:

  • The consistency of the treatment effect of an ACE-inhibitor based treatment regimen in patients with vascular disease or high risk of vascular disease: a combined analysis of individual data of ADVANCE, EUROPA, and PROGRESS trials

    European Heart Journal Date published:

  • Nuevas perspectivas en el tratamiento del paciente diabético. Estudio ADVANCE

    Hipertensión y Riesgo Vascular Date published:

  • Lowering Blood Pressure Reduces Renal Events in Type 2 Diabetes

    Journal of the American Society of Nephrology Date published: